The company’s stock price fell more than 12% in extended trading following the earnings announcement, partly due to lower-than-expected guidance for 2026 sales and revenue.

New partnership combines Shilpa Biologicals' development and manufacturing capabilities with SteinCares' regional commercialization platform Collaboration aims to expand patient access to cost-effecti ...

An Iowa nursing home worker who was criminally charged with stealing residents’ painkillers has agreed to surrender her ...

A St. Johns County builder is now headed to trial after a plea deal fell apart on Tuesday afternoon.